Nigeria Radiotherapy Market Report 2022 to 2030

Nigeria Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Nigeria Radiotherapy Market will reach a value of $xx Mn from $6 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in Nigeria is dominated by a few domestic players such as Accuray, Varian Medical Systems, and Siemens. The radiotherapy market in Nigeria is segmented into different types, technology, procedures, application, and end-user. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Nigeria Radiotherapy is increasing due to the rise in cancer cases in the country.

ID: IN10NGPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Nigeria AUTHOR: Dr. Vishwa Modhia

Buy Now

Nigeria Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Nigeria Radiotherapy Market will reach a value of $xx Mn from $6 Mn in 2022, growing at a CAGR of xx% during 2022-2030.

Nigeria is a lower middle-income, developing country located in West Africa with a coast on the Gulf of Guinea and the Atlantic Ocean. Cancer has remained at the top of the list of diseases that are indiscriminately reducing people's welfare and health around the world, particularly in developing nations such as Nigeria. Cancer kills roughly 80,000 people in Nigeria each year, and by 2030, low-middle-income countries such as Nigeria would account for 70% of the 13 Mn cancer fatalities expected globally. In Nigeria, there are seven government-run and one privately operated radiotherapy centre with megavoltage devices.

Each year, Nigeria has an estimated 233,911 cancer cases, including 124,815 new cases and 78,899 cancer deaths. Nigeria's government spent 3.4% of its GDP on healthcare in 2020.

Nigeria Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

Nigeria's federal government significantly boosted treatment capacity and capabilities at NHA. Furthermore, a public-private partnership arrangement at the Nigerian Sovereign Investment Authority/LUTH centre has donated a cobalt-60 machine at Imo International Health Systems, Ikeduru, as well as high-dose-rate equipment for numerous centres. Efforts to increase radiation access in Nigeria began in 1968 when LUTH purchased a 10 kV radiotherapy unit. These aspects could boost Nigeria's Radiotherapy Market.

Market restrains.

Common challenges encountered by LINAC users in Nigeria result in lengthy wait times for patients. Nigeria has inadequate healthcare insurance coverage, which reduces the affordability of these therapies for the general public. According to the World Health Organization, Nigeria's population of 170 Mn people necessitates the establishment of at least 170 cancer treatment centres. Nigeria now has about 9 centres, significantly fewer than what is required. According to the Directory of Radiotherapy Centres database, Africa's 160 radiotherapy clinics have a total of 189 linear accelerators (LINACS) and 88 cobalt-60 machines, with more than 60% located in South Africa, Egypt, and Morocco. This gap in radiation treatment capacity exists throughout Africa, but particularly in Nigeria. Despite this, it only contains 7 LINACs. These factors may deter new entrants into the Nigeria Radiotherapy Market.

Competitive Landscape

Key Players

Varian Medical Systems - Varian Medical Systems is a company that provides radiation therapy equipment such as linear accelerators and brachytherapy systems to healthcare facilities around the world, including in Nigeria
GE Healthcare - GE Healthcare is an international company that specializes in the development and manufacture of radiation therapy equipment such as linear accelerators and brachytherapy systems and supplies it to Nigeria
Siemens Healthineers - Siemens is a German company that provides a range of medical equipment, including radiation therapy equipment such as linear accelerators and CT simulators
Accuray - Accuray is a US-based company that provides radiation therapy equipment such as the CyberKnife System, which uses precision radiation to treat cancerous and non-cancerous tumours
IBA Worldwide - IBA is a Belgian company that provides radiation therapy equipment such as proton therapy systems and cyclotrons for the production of medical isotopes

Healthcare Policies and Reimbursement Scenarios

Radiotherapy regulations and reimbursement in Nigeria are governed by the National Nuclear Regulatory Agency (NNRA) and the National Health Insurance Scheme (NHIS), respectively. However, the reimbursement for radiotherapy services in Nigeria is limited and often inadequate. The cost of radiotherapy is generally high, and the NHIS reimbursement rates may not fully cover the cost of treatment.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.